PerkinElmer Genomics has a long history of screening and identifying patients with rare diseases. Since our founding in 1994, we have screened more than 7 million newborns. We help save the lives of thousands of babies every year.
Leveraging PerkinElmer’s position as an industry-leader in work-flow solutions and genetic expertise, we create unmatched efficiency, quality, and sustainability within the lab. These capabilities enable us to accelerate our report delivery and increase affordability empowering clinicians and researchers to utilize genetic testing earlier in the diagnostic process.
With a network of laboratories in China, India and USA, PerkinElmer Genomics can support research and testing collaborations around the globe. Our collaborators can access capabilities such as:
Sample Collection and Logistics
Collection packet design, manufacturing and distribution
Ability to support testing on different sample types: Dried blood spots (DBS), Saliva (SV), Whole blood (WB)
Microsampling with DBS provides convenient and inexpensive sample transportation
Clinical Grade Custom Assay Development and Testing Service Programs
PerkinElmer Genomics can build customized assays to the appropriate technology
Expertise in utilizing DBS for Mass spectrometry metabolites, Enzyme activity, Next Generation Sequencing, Nucleic acid analysis, and Immunoassays
Develop customized testing service programs in support of our collaborators’ clinical research needs
Versatile Delivery Models
Full service testing services via our network of clinically CAP certified global testing labs
Lab in Lab model
Customer contracted manufacturing services
Experience in Genomics
PerkinElmer Genomics has extensive experience in genomics via our team of certified Biochemical Genetics, Cytogenetics and Molecular Genetics experts.